220 related articles for article (PubMed ID: 27594673)
1. G protein-coupled estrogen receptor deficiency accelerates liver tumorigenesis by enhancing inflammation and fibrosis.
Wei T; Chen W; Wen L; Zhang J; Zhang Q; Yang J; Liu H; Chen BW; Zhou Y; Feng X; Yang Q; Bai X; Liang T
Cancer Lett; 2016 Nov; 382(2):195-202. PubMed ID: 27594673
[TBL] [Abstract][Full Text] [Related]
2. Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN-induced hepatocellular carcinoma.
Chen S; Zheng P; Wang W; Yi M; Chen P; Cai J; Li J; Peng Q; Ban Y; Zhou Y; Zeng Z; Li X; Xiong W; Li G; Xiang B
J Cell Physiol; 2018 Jun; 233(6):5002-5013. PubMed ID: 29227538
[TBL] [Abstract][Full Text] [Related]
3. NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice.
Liang S; Ma HY; Zhong Z; Dhar D; Liu X; Xu J; Koyama Y; Nishio T; Karin D; Karin G; Mccubbin R; Zhang C; Hu R; Yang G; Chen L; Ganguly S; Lan T; Karin M; Kisseleva T; Brenner DA
Gastroenterology; 2019 Mar; 156(4):1156-1172.e6. PubMed ID: 30445007
[TBL] [Abstract][Full Text] [Related]
4. Diethylnitrosamine-induced hepatocarcinogenesis is suppressed in lecithin:retinol acyltransferase-deficient mice primarily through retinoid actions immediately after carcinogen administration.
Shirakami Y; Gottesman ME; Blaner WS
Carcinogenesis; 2012 Feb; 33(2):268-74. PubMed ID: 22116467
[TBL] [Abstract][Full Text] [Related]
5. Epithelial Transforming Growth Factor-β Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma.
Mu X; Pradere JP; Affò S; Dapito DH; Friedman R; Lefkovitch JH; Schwabe RF
Gastroenterology; 2016 Mar; 150(3):720-33. PubMed ID: 26627606
[TBL] [Abstract][Full Text] [Related]
6. Growth arrest and DNA damage-inducible protein (GADD34) enhanced liver inflammation and tumorigenesis in a diethylnitrosamine (DEN)-treated murine model.
Chen N; Nishio N; Ito S; Tanaka Y; Sun Y; Isobe K
Cancer Immunol Immunother; 2015 Jun; 64(6):777-89. PubMed ID: 25832002
[TBL] [Abstract][Full Text] [Related]
7. Liver X receptor signaling is a determinant of stellate cell activation and susceptibility to fibrotic liver disease.
Beaven SW; Wroblewski K; Wang J; Hong C; Bensinger S; Tsukamoto H; Tontonoz P
Gastroenterology; 2011 Mar; 140(3):1052-62. PubMed ID: 21134374
[TBL] [Abstract][Full Text] [Related]
8. Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling.
Sun L; Beggs K; Borude P; Edwards G; Bhushan B; Walesky C; Roy N; Manley MW; Gunewardena S; O'Neil M; Li H; Apte U
Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G91-G104. PubMed ID: 27151938
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-22 ameliorates liver fibrogenesis by attenuating hepatic stellate cell activation and downregulating the levels of inflammatory cytokines.
Lu DH; Guo XY; Qin SY; Luo W; Huang XL; Chen M; Wang JX; Ma SJ; Yang XW; Jiang HX
World J Gastroenterol; 2015 Feb; 21(5):1531-45. PubMed ID: 25663772
[TBL] [Abstract][Full Text] [Related]
10. The inhibition of Hippo/Yap signaling pathway is required for magnesium isoglycyrrhizinate to ameliorate hepatic stellate cell inflammation and activation.
Li L; Zhou J; Li Q; Xu J; Qi J; Bian H
Biomed Pharmacother; 2018 Oct; 106():83-91. PubMed ID: 29957470
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice.
Meng F; Wang K; Aoyama T; Grivennikov SI; Paik Y; Scholten D; Cong M; Iwaisako K; Liu X; Zhang M; Österreicher CH; Stickel F; Ley K; Brenner DA; Kisseleva T
Gastroenterology; 2012 Sep; 143(3):765-776.e3. PubMed ID: 22687286
[TBL] [Abstract][Full Text] [Related]
12. COL6A3-derived endotrophin links reciprocal interactions among hepatic cells in the pathology of chronic liver disease.
Lee C; Kim M; Lee JH; Oh J; Shin HH; Lee SM; Scherer PE; Kwon HM; Choi JH; Park J
J Pathol; 2019 Jan; 247(1):99-109. PubMed ID: 30246318
[TBL] [Abstract][Full Text] [Related]
13. Babao Dan attenuates hepatic fibrosis by inhibiting hepatic stellate cells activation and proliferation via TLR4 signaling pathway.
Liang L; Yang X; Yu Y; Li X; Wu Y; Shi R; Jiang J; Gao L; Ye F; Zhao Q; Li R; Wei L; Han Z
Oncotarget; 2016 Dec; 7(50):82554-82566. PubMed ID: 27776340
[TBL] [Abstract][Full Text] [Related]
14. Capsaicin attenuates liver fibrosis by targeting Notch signaling to inhibit TNF-α secretion from M1 macrophages.
Sheng J; Zhang B; Chen Y; Yu F
Immunopharmacol Immunotoxicol; 2020 Dec; 42(6):556-563. PubMed ID: 32811220
[TBL] [Abstract][Full Text] [Related]
15. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
[TBL] [Abstract][Full Text] [Related]
16. Toll-Like Receptor 4-Independent Carbon Tetrachloride-Induced Fibrosis and Lipopolysaccharide-Induced Acute Liver Injury in Mice: Role of Hepatic Stellate Cells.
Kumar S; Wang J; Shanmukhappa SK; Gandhi CR
Am J Pathol; 2017 Jun; 187(6):1356-1367. PubMed ID: 28412299
[TBL] [Abstract][Full Text] [Related]
17. Role of growth factor receptor-bound 2 in CCl
Ge S; Xiong Y; Wu X; Xie J; Liu F; He J; Xiang T; Cheng N; Lai L; Zhong Y
Biomed Pharmacother; 2017 Aug; 92():942-951. PubMed ID: 28618656
[TBL] [Abstract][Full Text] [Related]
18. Hedgehog signaling pathway regulates hexavalent chromium-induced liver fibrosis by activation of hepatic stellate cells.
Yan J; Huang H; Liu Z; Shen J; Ni J; Han J; Wang R; Lin D; Hu B; Jin L
Toxicol Lett; 2020 Mar; 320():1-8. PubMed ID: 31756458
[TBL] [Abstract][Full Text] [Related]
19. Exosomal MALAT1 derived from hepatic cells is involved in the activation of hepatic stellate cells via miRNA-26b in fibrosis induced by arsenite.
Dai X; Chen C; Xue J; Xiao T; Mostofa G; Wang D; Chen X; Xu H; Sun Q; Li J; Wei Y; Chen F; Quamruzzaman Q; Zhang A; Liu Q
Toxicol Lett; 2019 Nov; 316():73-84. PubMed ID: 31513886
[TBL] [Abstract][Full Text] [Related]
20. Hepatic Stellate Cells Enhance Liver Cancer Progression by Inducing Myeloid-Derived Suppressor Cells through Interleukin-6 Signaling.
Hsieh CC; Hung CH; Chiang M; Tsai YC; He JT
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
